Defining the genetic and developmental events underlying human lymphatic vascular diseases

3 April 2025 12:00pm1:00pm
Professor Natasha Harvey is Head of the Lymphatic Development Laboratory and Director of the Centre for Cancer Biology at the University of South Australia and SA Pathology. Natasha received her PhD from the University of Adelaide and undertook postdoctoral training in the laboratory of Guillermo Oliver at St Jude Children’s Research Hospital, USA. Here, she focussed on defining the role of the homeobox transcription factor PROX1 in lymphatic vascular development. In 2005, she returned to Adelaide to establish her independent research program. Natasha’s work aims to understand how the lymphatic vasculature is constructed during development and how this process “goes wrong” in human lymphatic vessel pathologies. Her work in this field has been published in Development, Blood, Journal of Clinical Investigation, Science Translational Medicine and Nature.

Deadly cures: a venom-inspired drug candidate to treat ischemic injuries of the heart and brain

20 March 2025 12:00pm
Professor Glenn did his PhD at the University of Sydney before postdoctoral studies at the University of Oxford. After academic stints at the University of Sydney and the University of Connecticut Health Center, he joined the Institute for Molecular Bioscience in 2007. Glenn is a leader in the field of venoms-based drug and insecticide discovery. Glenn’s laboratory maintains one of the largest venom collections in the world, sourced from more than 500 species of venomous invertebrates. In 2023 Glenn received the Prime Minister’s Prize for Innovation for his translational work, and he was elected a Fellow of the Australian Academy of Science in 2024.